Selank

HOW IT WORKS (WHAT MAKES IT INTERESTING)

Research suggests Selank peptide influences multiple neurological pathways:

• GABAergic Allosteric Modulation – Acts as a positive allosteric modulator at GABA-A receptors, enhancing inhibitory neurotransmission without directly binding the benzodiazepine site
• Monoamine System Regulation – Influences serotonin, dopamine, and norepinephrine levels in hippocampus, frontal cortex, and hypothalamus
• BDNF Expression – Rapidly elevates brain-derived neurotrophic factor in hippocampus and prefrontal cortex, supporting neuroplasticity and memory consolidation
• Enkephalin Protection – Inhibits enzymes that degrade endogenous enkephalins, potentially extending their stress-regulatory effects
• Gene Expression Changes – Modulates expression of approximately 45 genes involved in neurotransmission within one hour of administration (including dopamine receptors Drd1a, Drd2, Drd5 and GABA transporters)
• Immunomodulation – Regulates IL-6 expression and T-helper cell cytokine balance, connecting peripheral immune function to central nervous system activity

COMMON RESEARCH APPLICATIONS

Anxiety & Stress Models: Generalized anxiety disorder studies, chronic stress paradigms, social anxiety protocols, stress-induced behavioral changes, cortisol dysregulation

Cognitive Function Research: Learning acquisition studies, memory retention protocols, attention deficit models, cognitive enhancement under stress, age-related memory decline, alcohol-induced memory impairment

Neuroprotection Studies: Oxidative stress models, ethanol-induced neurotoxicity, age-related cognitive decline, prenatal hypoxic stress effects, neuronal survival assays

Neuroplasticity Research: BDNF-mediated plasticity, synaptic remodeling, neurogenesis studies, cognitive resilience mechanisms, stress-induced neural adaptation

Immunomodulation Research: Neuroimmune interaction studies, cytokine regulation, T-cell balance research, inflammation-behavior connections, brain-immune axis investigation

Comparative Anxiolytic Studies: Benzodiazepine mechanism comparison, non-sedating anxiolytic development, withdrawal and dependency research, cognitive side effect profiling

Intended Use:

This peptide is intended for in vitro research only by qualified professionals. It is not for human or veterinary use, and must not be used in food, drugs, diagnostics, or cosmetics.

Disclaimer:

This compound has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. All use must follow institutional and regulatory guidelines.

Terms of Sale:

By purchasing from Modern Med, the buyer affirms they are a qualified researcher or institution. All sales are final. The purchaser assumes full responsibility for handling, use, and regulatory compliance.